Navigation Links
Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance

Partnership quadruples distribution of Corvalen(R) (D-ribose) products to

health practitioners

MINNEAPOLIS, and GREEN BAY, Wis., Oct. 29 /PRNewswire/ -- Bioenergy Life Science -- The Ribose Company, and Integrative Therapeutics, Inc. (ITI), a division of Enzymatic Therapy Inc. (ETI), today announced that they have entered into an exclusive co-marketing alliance. ITI will now sell the Corvalen(R) line of products, developed by Bioenergy Life Science, to its established health care practitioners.

Corvalen(R) is a medical food containing pure, proprietary D-ribose, a unique sugar made by the body to synthesize many important compounds, including DNA, RNA, and, most importantly, ATP, the "energy currency" of the cells. ATP (adenosine triphosphate) is critical to health and maintaining normal energy-dependent body functions. Ribose is the essential component in the making of ATP and as a medical food, Corvalen(R) is prescribed and used under the direction of a licensed healthcare practitioner.

Clinical research has shown that Corvalen(R) can help effectively manage diseases in which there is a deficiency in energy (i.e., ATP). D-Ribose has already been shown to increase functional capacity for patients with congestive heart failure (CHF), decrease fatigue caused by Chronic Fatigue Syndrome (CFS) and fibromyalgia (FMS), and enhance energy for athletes and others who need a natural boost.

"We are terrifically enthused about advancing the entire science of wellness with Bioenergy Life Science as our alliance partner," said Randy Rose, president and CEO of Enzymatic Therapy, Inc. "The research and product development synergies we have together will bring a number of patient and consumer health solutions forward that dramatically improve the quality of life for many."

Tom VonderBrink, president and chief operating officer of Bioenergy Life Science, concurred. "We are thrilled about the agreement with this quality leading company as it quadruples the number of representatives educating health care practitioners on the value of this significant emerging therapy," he said. "D-ribose is already changing the lives of many suffering from chronic energy-depleting conditions. It's also improving the quality of life for baby boomers as they reach the prime of their lives. Our collaboration will mean that more people will have access to this exciting breakthrough."

Research published in the Journal of Alternative and Complementary Medicine (12:9, 2006, 35-40) suggests that Corvalen(R) (D-ribose) provides metabolic support to accelerate cellular energy recovery and normal cellular functioning for patients with Chronic Fatigue Syndrome and fibromyalgia. "The research helped us pinpoint the energy-building benefit of Corvalen(R), and how it substantially reduces the debilitating symptoms of these devastating conditions," said Jacob Teitelbaum, MD, board-certified internist and author of the pilot study. "I think this study, and follow-up research now underway, will show Corvalen(R) to be one of the most important new nutrients evaluated over the next few years."

Bioenergy Inc.,, parent of Bioenergy Life Science, is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-ribose in health and wellness. Bioenergy Life Science products include Bioenergy Ribose(TM), a functional ingredient in the active lifestyle market; and Corvalen(R), and CorvalenM(R), clinical nutrition products giving metabolic support to patients with heart and muscle disease. Bioenergy Ribose is non-GMO certified. The product is also manufactured under the supervision of the Kashruth Division of the Orthodox Union. Toll-free order line is 866-267-8253.

Integrative Therapeutics, Inc., based in Green Bay, Wisconsin, is North America's leading manufacturer and distributor of proprietary, natural, dietary supplements for medical professionals and their patients. It is one of the first and only dietary supplement manufacturers that's an FDA-registered drug establishment and also a certified organic processor. For more than 30 years, ITI products have been used by medical professionals and researchers around the world. The company's products and ingredients are collectively the subject of over 2,500 independent, peer-reviewed-published clinical trials and studies. ITI's products are extensively used in research supported by major medical universities, hospital research centers and government agencies including the National Institutes of Health and the Veteran's Administration. Toll-free order line is 800-931-1709.

SOURCE Bioenergy Life Science
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Federal bioenergy lab will give Wisconsin a chance to shine
2. UW-Madison to receive $125M for bioenergy research center
3. Advantages of Roche Applied Science amplification products
4. Tools for Proteomic Science II
5. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
6. Food science: increasing crop yields
7. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
8. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
9. NanoRite Innovation Center opens with small science, big promise
10. Midwest life science stocks kept sizzling in Q2
11. Perscitus Biosciences secures $250K Commerce loan
Post Your Comments:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):